Bain Capital is making its latest biotech bid in Japan, where it plans to acquire Mitsubishi Tanabe Pharma Corp. The Boston-based private investment firm is buying Tanabe Pharma from Mitsubishi ...
Hosted on MSN23d
Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe PharmaBain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...
Hosted on MSN1mon
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bnUS private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe Pharma in a deal valued at approximately Y510bn ($3.3bn). The ...
TOKYO : Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion ...
TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...
Ropes & Gray, Morrison & Foerster and Big Four Japanese firm Mori Hamada are advising Bain Capital on the $3.3 billion acquisition of Mitsubishi Tanabe Pharma Corporation (MTPC). MTPC, which is ...
TOKYO (Reuters) -U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback